DURECT Corp
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About DRRX
DURECT Corporation is a late-stage biopharmaceutical company. The Company is engaged in the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Its lead drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in alcoholic hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which the FDA has granted a Fast Track and a Therapy designation, and metabolic dysfunction-associated steatohepatitis (MASH) is also being explored. Its commercial pharmaceutical product includes POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology. It has developed a proprietary drug product for the treatment of ADHD called Methydur.
Find out what a historical investment in DURECT Corp would be worth today using our DRRX stock calculator.
$19.37M
-
0.00%
4
$0.65
$0.60
$0.00
$1.74
$0.48
Ready to start your investing journey with Stake?
Open an accountDRRX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DRRX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DRRX
on Stake
Buy DRRX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of DRRX from only US$10 with fractional shares
